Swiss­Med­Tech expects “worst case sce­na­rio” for medi­cal device manufacturers

The Mutu­al Reco­gni­ti­on Agree­ment (MRA) bet­ween the EU and Switz­er­land remains unsi­gned. If no agree­ment is rea­ched with regard to the trade agree­ment, Switz­er­land will (con­ti­nue to) be con­side­red a “third coun­try” in the future with respect to medi­cal devices.

What this means for Swiss manu­fac­tu­r­ers is that they will be requi­red to satis­fy the requi­re­ments appli­ca­ble to third count­ries for all medi­cal devices as of 26 May 2020.

What this means for Euro­pean dis­tri­bu­tors which purcha­se devices in Switz­er­land is that they will be requi­red to com­ply not only with the obli­ga­ti­ons for dis­tri­bu­tors in accordance with Artic­le 14 of the MDR but pos­si­bly also with tho­se of importers in accordance with Artic­le 13 of the MDR, unless a poli­ti­cal reso­lu­ti­on in the mat­ter of the MRA is rea­ched pri­or to 26 May 2020.


Stay up-to-date

We use your email address exclusively for sending our newsletter. You have the right to revoke your consent at any time with effect for the future. For further information, please refer to our privacy policy.